Prospective multicenter phase II study of irinotecan as third-line therapy in metastatic colorectal cancer and progression after bolus and infusional 5-fluorouracil.

Joerg Thomas Hartmann; Karin Oechsle; Elke Jäger; Hans Edgar Reis; Cornelie Haag; Norbert Niederle; Hans-Joachim Wilke; Karl-Heinz Pflüger; Salah Al Batran; Thomas Büchele

doi:10.1097/01.cad.0000127144.73043.57

Prospective multicenter phase II study of irinotecan as third-line therapy in metastatic colorectal cancer and progression after bolus and infusional 5-fluorouracil.

NobleID: NI6P54W81R59S06
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/C4FF3DB3

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/C4FF3DB3.svg?ark=w1%2F20260515%2FC4FF3DB3&value=id)](https://nobleid.org/work/w1/20260515/C4FF3DB3)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Joerg Thomas Hartmann

Claim authorship of this work

Prospective multicenter phase II study of irinotecan as third-line therapy in metastatic colorectal cancer and progression after bolus and infusional 5-fluorouracil.

NobleID: NI6P54W81R59S06
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/C4FF3DB3

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/C4FF3DB3.svg?ark=w1%2F20260515%2FC4FF3DB3&value=id)](https://nobleid.org/work/w1/20260515/C4FF3DB3)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Joerg Thomas Hartmann

Claim authorship of this work